Literature DB >> 14509222

[A case of pseudo-Bartter's syndrome induced by long-term ingestion of furosemide delivered orally through health tea].

Atsushi Numabe1, Atsuko Ogata, Minoru Abe, Masaki Takahashi, Koichi Kono, Masaru Arakawa, Toshihiko Ishimitsu, Tamio Ieiri, Hiroaki Matsuoka, Shigeru Yagi.   

Abstract

A 32-year-old woman with a three-year history of muscle weakness and hypokalemia, was admitted to our hospital because of hypokalemic periodic paralysis. Clinical and laboratory findings were consistent with Bartter's syndrome. Although she denied any ingestion of diuretics substantial quantities of furosemide were detected in her urine. She had been drinking health tea which contained about 90 mg of furosemide per teabag daily for five years. Four years after discontinuation of drinking the tea, the hypokalemia was completely ameliorated, but poor renal concentration ability is still present. We conclude that is a case of pseudo-Bartter's syndrome that was caused by long-term ingestion of the health tea supplemented illegally with furosemide, and suspect that such cases may be observed more frequently than currently thought.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14509222

Source DB:  PubMed          Journal:  Nihon Jinzo Gakkai Shi        ISSN: 0385-2385


  3 in total

1.  Furosemide-induced tubular dysfunction responding to prostaglandin synthesis inhibitor therapy in a child with nephrotic syndrome.

Authors:  T Harish Varma; Ashish Sharma; S Santhiya; Lesa Dawman; Karalanglin Tiewsoh
Journal:  CEN Case Rep       Date:  2018-03-22

2.  Furosemide-induced severe hypokalemia with rhabdomyolysis without cardiac arrest.

Authors:  Wolfgang Ruisz; Claudia Stöllberger; Josef Finsterer; Franz Weidinger
Journal:  BMC Womens Health       Date:  2013-07-09       Impact factor: 2.809

3.  Primary molecular disorders and secondary biological adaptations in bartter syndrome.

Authors:  Georges Deschênes; Marc Fila
Journal:  Int J Nephrol       Date:  2011-09-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.